The importance of gut microbiota in reducing the burden of alcohol-related liver disease and liver cancer was demonstrated in a novel pilot study presented at The Digital International Liver Congress 2020 held virtually on Aug 27-29 (2020).
The study examined whether the transfer of faecal bacteria from a healthy individual to a patient (known as a faecal microbiota transplantation or FMT) could reduce cravings for alcohol as the first step for use in subsequent larger trials.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!